News
LITMUS Molecular Design Announces the Addition of Dr. Herbert Y. Meltzer to Scientific Advisory Board
01 December 2007
Dr. Meltzer received his B.A. from Cornell University in 1958, an M.A. in Chemistry from Harvard University in 1959, and his M.D. from Yale University School of Medicine in 1963. Dr. Meltzer received his psychiatric training at the Massachusetts Mental Health Center. Dr. Meltzer has been professor of psychiatry at the University of Chicago and Case Western Reserve University School of Medicine. Dr. Meltzer is currently Bixler/Johnson/Mays Professor of Psychiatry, Division Director Psychopharmacology, and Investigator at the Center for Molecular Neuroscience and Pharmacology at the Vanderbilt University School of Medicine.
Dr. Meltzer is recipient of the Daniel Efron Research Award of the ACNP, recently served as editor of Psychopharmacology: The Third Generation of Progress, co-editor of Neuropsychopharmacology, and past president of that group. Dr. Meltzer is director of the research grant review program for the National Alliance for Research in Schizophrenia and Depression (NARSAD). He has received the Noyes Prize of the Commonwealth of Pennsylvania, the Edward J. Sachar Award from Columbia University, the Lieber Prize from NARSAD, and the Stanley Dean Award of the American College of Psychiatry for his research on schizophrenia and the Gold Medal Award of the Society of Biological Psychiatry.
Dr. Meltzer is on the editorial board of the Archives of General Psychiatry and 7 other scientific journals. Dr. Meltzer's major research interests are the psychopharmacologic treatment of schizophrenia, the neurochemistry of schizophrenia, the mechanism of action of new antipsychotic drugs, pharmacoeconomics, and cognitive studies in schizophrenia.